These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3109786)

  • 1. An evaluation of four methods for the detection of heterozygous cystinuria.
    Giugliani R; Ferrari I; Greene LJ
    Clin Chim Acta; 1987 Apr; 164(2):227-33. PubMed ID: 3109786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and genetic studies in 43 patients with classic cystinuria.
    Byrd DJ; Lind M; Brodehl J
    Clin Chem; 1991 Jan; 37(1):68-73. PubMed ID: 1899064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterozygous cystinuria and urinary lithiasis.
    Giugliani R; Ferrari I; Greene LJ
    Am J Med Genet; 1985 Dec; 22(4):703-15. PubMed ID: 3934971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reference values of urinary excretion of cystine and dibasic aminoacids: classification of patients with cystinuria in the Valencian Community, Spain.
    Guillén M; Corella D; Cabello ML; García AM; Hernández-Yago J
    Clin Biochem; 1999 Feb; 32(1):25-30. PubMed ID: 10074888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of cyanide-nitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: a standardized dilution procedure.
    Finocchiaro R; D'Eufemia P; Celli M; Zaccagnini M; Viozzi L; Troiani P; Mannarino O; Giardini O
    Urol Res; 1998; 26(6):401-5. PubMed ID: 9879820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cystinuria.
    Milliner DS
    Endocrinol Metab Clin North Am; 1990 Dec; 19(4):889-907. PubMed ID: 2081517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of total cystine and the dibasic amino acids arginine, lysine and ornithine in relation to genetic findings in patients with cystinuria treated with sulfhydryl compounds.
    Fjellstedt E; Harnevik L; Jeppsson JO; Tiselius HG; Söderkvist P; Denneberg T
    Urol Res; 2003 Dec; 31(6):417-25. PubMed ID: 14586528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Distribution of cystinuria subtypes in the Democratic Republic of Germany].
    Grimm U; Steinhauser I; Lubs H; Seidlitz G
    Z Urol Nephrol; 1988 Dec; 81(12):719-23. PubMed ID: 3223107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cystinuria: description of a simple method of determination and our 5-year clinical experience].
    Guerra A; Borghi L; Meschi T; Novarini A
    Acta Biomed Ateneo Parmense; 1990; 61(1-2):85-90. PubMed ID: 2151909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and genetic studies in cystinuria: observations on double heterozygotes of genotype I-II.
    Morin CL; Thompson MW; Jackson SH; Sass-Kortsak A
    J Clin Invest; 1971 Sep; 50(9):1961-76. PubMed ID: 5564399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of cystinuria among stone-forming patients in region of Brazil.
    Giugliani R; Ferrari I; Greene LJ
    Urology; 1986 Jan; 27(1):38-40. PubMed ID: 3942020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystinuria phenotyping by oral lysine and arginine loading.
    de Sanctis L; Bonetti G; Bruno M; De Luca F; Bisceglia L; Palacin M; Dianzani I; Ponzone A
    Clin Nephrol; 2001 Dec; 56(6):467-74. PubMed ID: 11770798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot screening programme for cystinuria in the Valencian community.
    Cabello-Tomás ML; García-Gómez AM; Guillén-Domínguez ML
    Eur J Epidemiol; 1999 Aug; 15(7):681-4. PubMed ID: 10543360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A modified cyanide-nitroprusside method for quantifying urinary cystine concentration that corrects for creatinine interference.
    Nakagawa Y; Coe FL
    Clin Chim Acta; 1999 Nov; 289(1-2):57-68. PubMed ID: 10556653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cystine as a risk factor of the stone formation in kidney: the reference value range of urinary excretion, the stage diagnosis of cystine metabolism disorder].
    Gres AA; Nitkin DM; Juraha TM; Sivakow AA
    Urologiia; 2016 Aug; (4):10-14. PubMed ID: 28247719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of a qualitative screening test to a quantitative measurement of urinary cystine and homocystine.
    Wu JT; Wilson LW; Christensen S
    Ann Clin Lab Sci; 1992; 22(1):18-29. PubMed ID: 1739270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid chromatographic-mass spectrometric analysis for screening of patients with cystinuria, and identification of cystine stone.
    Watanabe H; Sugahara K; Inoue K; Fujita Y; Kodama H
    J Chromatogr; 1991 Aug; 568(2):445-50. PubMed ID: 1783649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infrared vibrational spectroscopy: a rapid and novel diagnostic and monitoring tool for cystinuria.
    Oliver KV; Vilasi A; Maréchal A; Moochhala SH; Unwin RJ; Rich PR
    Sci Rep; 2016 Oct; 6():34737. PubMed ID: 27721432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective analysis and classification of patients with cystinuria identified in a newborn screening program.
    Goodyer PR; Clow C; Reade T; Girardin C
    J Pediatr; 1993 Apr; 122(4):568-72. PubMed ID: 8463902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of cystinuria among elementary schoolchildren in Eskisehir, Turkey.
    Aydogdu SD; Kirel B; Coskun T; Kose S
    Scand J Urol Nephrol; 2009; 43(2):138-41. PubMed ID: 19096983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.